Biolase Cuts Jobs Citing a Weak Capital Equipment Marketplace
Dental laser maker Biolase Technology has slashed 20 percent of its domestic workforce. The company will save $2 million a quarter as a result. Additional […]
Blog
OneMedForum 2009: Panels and Speakers
The OneMedPlace finance conference for emerging med tech companies, the OneMedForum, will be held January 13-14 in San Francisco. Click here to learn more. Our […]
DexCom: CE Mark Approval for Continuous Glucose Monitor
DexCom’s short term continuous glucose monitor, The Seven, has received CE Mark approval enabling commercialization in the EU and the countries in Asia and Latin […]
Terminated: Minrad International Ends Agreement with RxElite
Minrad International has terminated its distribution agreement with RxElite. The action was taken after the RxElite failed to pay $5.6 million in accounts owed to […]
Mike Landess’ Battle with Prostate Cancer
A quick shout to Mike Landess, a Denver, CO newsman who this week released a half hour DVD special on prostate cancer (check out his […]
[Video Profile] Interview with Michael Fons, VP Corporate Development at Inovio Biomedical
Inovio Biomedical’s electroporation technology uses brief, controlled electrical pulses to increase cellular uptake of gene expression in DNA-based treatments; this enhances the potency of DNA-based […]
AngioDynamics: Irreversible Electroporation Shows Early Promise
AngioDynamics announced the first percutaneous use of NanoKnife, an irreversible electroporation (IRE) device. Although its too early to estimate the product’s prospects, under AngioDynamics watch, […]
Trod Medical: FDA 510(k) Clearance for Encage
Trod Medical has received FDA 510(k) clearance for Encage, a minimally invasive technology for soft tissue ablation. The surgical system allows for precise percutaneous ablation […]
Liquidity Crisis: Minrad International Slashes Jobs, Evaluates Options
In an effort to improve its cost structure and conserve cash, Minrad International said it would layoff 35 percent of its workforce, or some 50 […]
SyntheMed: FDA Clearance for SinusShield
SyntheMed, of Iselin, NJ, has received FDA 510(k) clearance for SinusShield, a bioresorbable membrane to prevent post-operative adhesions from forming after nasal and sinus surgeries. […]